Abstract
Herpes simplex virus (HSV) has a long and confusing history. More than 2,500 years ago, Hippocrates first used the word “herpes,” derived from the Greek word “to creep,” to describe how the lesions of this contagious ulcerative disease seemed to creep or crawl along the skin (Herpes 8:23–27, 2001). Galen first noted that recurrences develop at the same anatomic site. However, over time, the word herpes was used to describe many skin conditions from lupus to zoster. The definition of herpes (particularly oral lesions) became more rigorous in the seventeenth century. In the 1830s, recurrent genital herpes was described and 60 years later was identified as a “vocational disease”—a sexually transmitted infection (STI). The virus itself was not identified until the 1950s. In 1971, it was proposed that two different types of HSV caused infection. HSV-1 commonly causes labial or pharyngeal infection, and transmission is primary by nongenital contact. HSV-2 typically affects the genital area and is transmitted by intimate sexual contact. However, both viruses are capable of causing either genital or oral-pharyngeal infections that appear identical on examination. In the United States, HSV infection is one of the most common STIs and is the leading cause of genital ulcers.
From: Current Clinical Practice: Sexually Transmitted Diseases: A Practical Guide for Primary Care Edited by: A. L. Nelson and J. A. Woodward © Humana Press, Totowa, NJ
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Roizman B, Whitley RJ. The nine ages of herpes simplex virus. Herpes. 2001;8:23–7.
Xu F, Sternberg MR, Kottiri BJ, et al. Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. JAMA. 2006;296(8):964–73.
Yeung-Yue KA, Brentjens MH, Lee PC, Tyring SK. Herpes simplex viruses 1 and 2. Dermatol Clin. 2002;20:249–66.
Mertz GJ, Benedetti J, Ashley R, Selke SA, Corey L. Risk factors for the sexual transmission of genital herpes. Ann Intern Med. 1992;116:197–202.
Corey L, Wald A, Patel R, et al. Once-daily valacyclovir to reduce the risk of transmission of genital herpes. N Engl J Med. 2004;350:11–20.
National Institute of Allergy and Infectious Diseases. Workshop summary: scientific evidence on condom effectiveness for sexually transmitted disease (STD) prevention. Washington, DC: National Institutes of Health, Department of Health Services; 2001. Available from: http://www.niaid.nih.gov/dmid/stds/condomreport.pdf. Accessed 4 June 2005.
World Health Organization. Global prevalence and incidence of selected curable sexually transmitted infections: overview and estimates. Geneva: World Health Organization; 2001. Available from: http://www.who.int/emc-documents/STIs/whocdscsredc200110c.html. Accessed 10 July 2005.
Schacker T. The role of HSV in the transmission and progression of HIV. Herpes. 2001;8:46–9.
Schacker T, Ryncarz AJ, Goddard J, Diem K, Shaughnessy M, Corey L. Frequent recovery of HIV-1 from genital herpes simplex virus lesions in HIV-1-infected men. JAMA. 1998;280:61–6.
Mole L, Ripich S, Margolis D, Holodniy M. The impact of active herpes simplex virus infection on human immunodeficiency virus load. J Infect Dis. 1997;176:766–70.
Wald A, Link K. Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis. J Infect Dis. 2002;185:45–52.
Wald A. Herpes simplex virus type 2 transmission: risk factors and virus shedding. Herpes. 2004;11:130A–7.
Wald A, Langenberg AG, Link K, et al. Effect of condoms on reducing the transmission of herpes simplex virus type 2 from men to women. JAMA. 2001;285:3100–6.
Cherpes TL, Meyn LA, Krohn MA, Hillier SL. Risk factors for infection with herpes simplex virus type 2: role of smoking, douching, uncircumcised males, and vaginal flora. Sex Transm Dis. 2003;30:405–10.
Langenberg AG, Corey L, Ashley RL, Leong WP, Straus SE. A prospective study of new infections with herpes simplex virus type 1 and type 2. Chiron HSV Vaccine Study Group. N Engl J Med. 1999;341:1432–8.
Lafferty WE, Downey L, Celum C, Wald A. Herpes simplex virus type 1 as a cause of genital herpes: impact on surveillance and prevention. J Infect Dis. 2000;181:1454–7.
Wald A, Zeh J, Selke S, et al. Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons. N Engl J Med. 2000;342:844–50.
Wald A, Corey L, Cone R, Hobson A, Davis G, Zeh J. Frequent genital herpes simplex virus 2 shedding in immunocompetent women. Effect of acyclovir treatment. J Clin Invest. 1997;99:1092–7.
Bryson Y, Dillon M, Bernstein DI, Radolf J, Zakowski P, Garratty E. Risk of acquisition of genital herpes simplex virus type 2 in sex partners of persons with genital herpes: a prospective couple study. J Infect Dis. 1993;167:942–6.
Koelle DM, Benedetti J, Langenberg A, Corey L. Asymptomatic reactivation of herpes simplex virus in women after the first episode of genital herpes. Ann Intern Med. 1992;116:433–7.
Benedetti J, Corey L, Ashley R. Recurrence rates in genital herpes after symptomatic first episode infection. Ann Intern Med. 1994;121:847–54.
Kimberlin DW, Rouse DJ. Clinical practice. Genital herpes. N Engl J Med. 2004;350:1970–7.
Corey L, Adams HG, Brown ZA, Holmes KK. Genital herpes simplex virus infections: clinical manifestations, course, and complications. Ann Intern Med. 1983;98:958–72.
Patel R, Boselli F, Cairo I, Barnett G, Price M, Wulf HC. Patients’ perspectives on the burden of recurrent genital herpes. Int J STD AIDS. 2001;12:640–5.
Sweet RL, Gibbs RS. Herpes simplex virus infection. In: Sweet RL, Gibbs RS, editors. Infectious diseases of the female genital tract. 4th ed. Philadelphia, PA: Lippincott, Williams & Wilkins; 2002. p. 101–17.
Kessler HA, Baker DA, Brown ZA, Leone PA. Herpesvirus management: special considerations for the female patient. A monograph based on a symposium held May 6, New York, NY: New World Health; 2002.
Ebel C, Wald A. Managing herpes: how to live and love with a chronic STD. 3rd ed. Research Park Triangle, NC: American Social Health Association; 2002.
Kaufman RH, Gardner HL, Rawls WE, Dixon RE, Young RL. Clinical features of herpes genitalis. Cancer Res. 1973;33:1446–51.
Benedetti JK, Zeh J, Corey L. Clinical reactivation of genital herpes simplex virus infection decreases in frequency over time. Ann Intern Med. 1999;131:14–20.
Ashley-Morrow R, Krantz E, Wald A. Time course of seroconversion by HerpesSelect ELISA after acquisition of genital herpes simplex virus type 1 (HSV-1) or HSV-2. Sex Transm Dis. 2003;30:310.
Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines 2002. MMWR Recomm Rep. 2002;51:1–78.
Diaz-Mitoma F, Sibbald RG, Shafran SD, Boon R, Saltzman RL. Oral famciclovir for the suppression of recurrent genital herpes: a randomized controlled trial. Collaborative Famciclovir Genital Herpes Research Group. JAMA. 1998;280:887–92.
Tyring SK, Baker D, Snowden W. Valacyclovir for herpes simplex virus infection: longterm safety and sustained efficacy after 20 years experience with acyclovir. J Infect Dis. 2002;186:S40–6.
Parks DG, Greenway FL, Pack AT. Prevention of recurrent herpes simplex type II infection with lithium carbonate. Med Sci Res. 1988;16:971–2.
Workowski KA, Berman S. Sexually transmitted disease treatment guidelines. 2010. Centers for Disease Control and Prevention. Division of STD Prevention National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention. MMWR Recomm Rep. 2010;59(RR-12):1–110.
Alexander L, Naisbett B. Patient and physician partnerships in managing genital herpes. J Infect Dis. 2002;186:S57–65.
Brown ZA, Gardella C, Wald A, Morrow RA, Corey L. Genital herpes complicating pregnancy. Obstet Gynecol. 2005;106(4):845–56.
Eskild A, Jeansson S, Stray-Pedersen B, Jenum PA. Herpes simplex virus type-2 infection in pregnancy: no risk of fetal death: results from a nested case–control study within 35,940 women. BJOG. 2002;109:1030–5.
Brown Z. Preventing herpes simplex virus transmission to the neonate. Herpes. 2004;11:175A–86.
Kimberlin DW. Neonatal herpes simplex infection. Clin Microbiol Rev. 2004;17(1):1–13.
Smith JR, Cowan FM, Munday P. The management of herpes simplex virus infection in pregnancy. Br J Obstet Gynaecol. 1998;105:255–60.
Watts DH, Brown ZA, Money D, et al. A double-blind, randomized, placebo-controlled trial of acyclovir in late pregnancy for the reduction of herpes simplex virus shedding and cesarean delivery. Am J Obstet Gynecol. 2003;188:836–43.
Thung SF, Grobman WA. The cost-effectiveness of routine antenatal screening for maternal herpes simplex virus-1 and -2 antibodies. Am J Obstet Gynecol. 2005;192:483–8.
Baker D, Brown Z, Hollier LM, et al. Cost-effectiveness of herpes simplex virus type 2 serologic testing and antiviral therapy in pregnancy. Am J Obstet Gynecol. 2004;191:2074–84.
American College of Obstetricians and Gynecologists. ACOG Practice Bulletin. Management of herpes in pregnancy. Number 8 October 1999. Clinical management guidelines for obstetrician-gynecologists. Int J Gynaecol Obstet. 2000;68:165–73.
Sheffield JS, Hollier LM, Hill JB, Stuart GS, Wendel GD. Acyclovir prophylaxis to prevent herpes simplex virus recurrence at delivery: a systematic review. Obstet Gynecol. 2003;102:1396–403.
American College of Obstetricians and Gynecologists (ACOG). Management of herpes in pregnancy. Washington, DC: ACOG; 2007 (ACOG practice bulletin; no. 82).
Wald A, Langenberg AG, Krantz E, et al. The relationship between condom use and herpes simplex virus acquisition. Ann Intern Med. 2005;143(10):707–13.
Rana RK, Pimenta JM, Rosenberg DM, et al. Sexual behaviour and condom use among individuals with a history of symptomatic genital herpes. Sex Transm Infect. 2006;82(1):69–74.
National Institute of Allergy and Infectious Disease. Genital herpes. Washington DC: National Institutes of Health, Department of Health Services; 2011. Available from: http://www.niaid.nih.gov/topics/genitalherpes/research/researchreport.pdf. Accessed 24 May 2012.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Parks, D.G. (2013). Genital Herpes. In: Skolnik, N., Clouse, A., Woodward, J. (eds) Sexually Transmitted Diseases. Current Clinical Practice. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-499-9_2
Download citation
DOI: https://doi.org/10.1007/978-1-62703-499-9_2
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-498-2
Online ISBN: 978-1-62703-499-9
eBook Packages: MedicineMedicine (R0)